July 16, 2010 – Agfa HealthCare announced this week that both its DX-D 500n and DX-D 300 direct radiography (DR) systems now are available for sale in the United States.
July 16, 2010 – High demand has led Positron Corp. to increase production of Attrius positron emission tomography (PET) scanner with its joint venture, Neusoft Positron Medical Systems, the company announced recently.
July 15, 2010 -- Carestream Health has filed a lawsuit against Caliper Life Sciences alleging infringement of a patent covering multimodal in vivo imaging.
July 14, 2010 -- Philips Radiation Oncology has launched a project to triple its engineering staff dedicated to cancer care technology solutions by July 2012. The project includes plans to more than double its workforce in the Madison area by July 2011.
July 14, 2010 – HP this week introduced a new program to support and accelerate the adoption of electronic health records (EHR) among hospitals and physicians.
July 14, 2010 – Devicor Medical Products Inc. announced this week the company completed the acquisition of Ethicon Endo-Surgery’s (EES) breast care business. The division sells products designed to help doctors diagnose breast cancer at early stages while minimizing patient discomfort. The business will formally be known as Mammotome, a division of Devicor.
July 12, 2010 – A new beverage has been released that masks the taste of oral iodinated contrast used in abdominal study CT scans. Breeza, by Beekley Corp., was developed in response to industry requests for a beverage to deliver oral iodinated contrast that patients would find more palatable, enabling them to drink the entire volume within the allotted time.
July 12, 2010 – AngioDynamics announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex port technology, to include low-profile and mini models for repeated treatments such as chemotherapy and for use with computed tomography (CT).
July 12, 2010 – GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms.
July 12, 2010 – Lantheus Medical Imaging Inc. today announced that it has acquired the balance of the worldwide rights for gadofosveset trisodium, a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent that it currently markets in the United States as Ablavar.
